FDA: No plans to crack down on Cinnabon

The Food and Drug Administration (FDA) on Thursday said it has no plans to follow the lead of European regulators who are cracking down on Cinnabon. 

The FDA on Thursday said it has no qualms with the cinnamon roll maker, even as the Danish Veterinary and Food Administration is telling its own bakeries that their cinnamon rolls and twists don't comply with European law.

ADVERTISEMENT
"At this time, the FDA does not have any evidence of any problems with any cinnamon flavored products," FDA spokeswoman Theresa Eisenman said in a statement. "To the best of our knowledge, Cinnabon products are being manufactured following current FDA good manufacturing practices." 

The Danish Veterinary and Food Administration asked bakers to sprinkle less cinnamon on kanelsnegel, the Danish word for cinnamon roll, and on kanelstang, the Danish word for cinnamon twist.

According to the Danish regulator, much of the cinnamon used in bakeries there contains too much coumarin, a chemical compound that is common in cinnamon and can cause liver damage at excessive levels.

But in the U.S., regulators have no plans to crack down on Cinnabon and other bakeries. The FDA said three types of cinnamon are listed as GRAS substances, which means they are generally recognized as safe, when taken in normal portions. 

However, the FDA said that "food containing any added coumarin is deemed to be adulterated."

"Under the GRAS rules, the amount of cinnamon used should not exceed the amount needed for the intended physical, nutrition, or other technical effect (such as flavoring) in food," the FDA said.

More in Healthcare

FDA drug tracing regs start Jan. 1, health group asks for leniency

Read more »